Federal Capture Intelligence

Top DoD biological product (except diagnostic) manufacturing contractors (NAICS 325414)

Contract actions: October 1, 2021 – October 23, 2026 Updated October 24, 2026 Department of Defense agency guide NAICS 325414 · Biological Product (except Diagnostic) Manufacturing
Latest 12 months
$79.4M
Net obligations · Up $50.4M vs. $29.0M preceding
Prime contractors
14
With positive obligations in the latest 12 months

Research the DoD federal contracting market for biological product (except diagnostic) manufacturing under NAICS 325414. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and potential recompete research leads.

Contract obligation trends for Biological Product (except Diagnostic) Manufacturing at the Department of Defense

Federal records show $3.5B in net obligations across 326 awards in Biological Product (except Diagnostic) Manufacturing at the Department of Defense from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.15% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 173.6% from $29.0M to $79.4M. 2 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.

FY27 year-to-date: $0 versus $45K through the same date in FY26 (−100.0%).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$3.4B126Complete
FY2023−$87.5M109Complete
FY2024$71.3M111Complete
FY2025$29.2M85Complete
FY2026$79.5M54Complete

Market at a glance

All reported prime contract awards
All-period net obligations
$3.5B
326 awards · 56 prime contractors
Latest 12-month movement
+173.6%
$79.4M vs. $29.0M
Leading eight prime share
99.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.15% of $2.3T in agency-wide net obligations.
Set-aside share when reported
2.5% of 204 awards with reported set-aside status.
Set-aside reporting
5 set aside · 199 no set-aside · 122 not reported

What changed in the last 12 months?

Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.

Competitive shifts

SANOFI VACCINES US INC. lost the most market share
55.76%→11.74%−44.0 percentage points
The contractor now ranks #3 by positive obligations, based on 11 reported actions.
SEQIRUS USA INC had the largest increase in reported obligations
$4.6M→$12.2M+$7.6M
The contractor now ranks #2 by positive obligations and accounts for 15.4% of positive obligations, based on 2 reported actions.

Market structure

This market grew faster than 99.3% of comparable agency NAICS markets
+173.6%Agency median −53.2%
The agency comparison covers 509 comparable NAICS markets.

Buyer demand

Reported obligations through DLA TROOP SUPPORT increased
$20.8M→$74.4M+$53.6M
Latest-period activity spans 15 awards across 4 prime contractors.

Award activity

How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.

93.7% of positive obligations were attributed to DLA TROOP SUPPORT. That represents $74.4M, up $53.6M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. DLA TROOP SUPPORT93.7% · $74.4M · up $53.6M
  2. ARMY MMDA - MM4.7% · $3.7M · up $220K
  3. KIMBROUGH AMB CC MEADE - MM1.2% · $926K · down $855K
  4. NAV MED CTR SAN DIEGO CA - MM0.14% · $113K · up $113K
  5. WALTER REED ARMY INST OF RES - MM0.10% · $77K · down $19K
  6. All other reported offices0.21% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    DLA TROOP SUPPORT

    #1Rank unchanged

    Latest 12 months

    $74.4M

    93.7% of positive obligations

    Versus preceding 12 months

    +$53.6M

    4 active prime contractors · 15 awards

    View office comparison and evidence

    Reported obligations increased 258.2% from $20.8M to $74.4M. The office’s share of positive obligations moved from 71.6% to 93.7%, a change of +22.1 percentage points.

    The latest period contains 17 actions across 15 awards and 2 newly active prime contractors. The preceding period contained 2 active prime contractors and 16 awards.

    Leading award-level changes

  2. Reported funding office

    ARMY MMDA - MM

    #2Rank unchanged

    Latest 12 months

    $3.7M

    4.7% of positive obligations

    Versus preceding 12 months

    +$220K

    1 active prime contractor · 2 awards

    View office comparison and evidence

    Reported obligations increased 6.3% from $3.5M to $3.7M. The office’s share of positive obligations moved from 12.1% to 4.7%, a change of −7.4 percentage points.

    The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 3 awards.

  3. Reported funding office

    KIMBROUGH AMB CC MEADE - MM

    #3Up 1 from #4

    Latest 12 months

    $926K

    1.2% of positive obligations

    Versus preceding 12 months

    −$855K

    1 active prime contractor · 2 awards

    View office comparison and evidence

    Reported obligations decreased 48.0% from $1.8M to $926K. The office’s share of positive obligations moved from 6.1% to 1.2%, a change of −5.0 percentage points.

    The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 3 awards.

  4. Reported funding office

    NAV MED CTR SAN DIEGO CA - MM

    #4New to the positive-obligation ranking

    Latest 12 months

    $113K

    0.14% of positive obligations

    Versus preceding 12 months

    +$113K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $113K. The office’s share of positive obligations moved from 0% to 0.14%, a change of +0.1 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  5. Reported funding office

    WALTER REED ARMY INST OF RES - MM

    #5Up 3 from #8

    Latest 12 months

    $77K

    0.10% of positive obligations

    Versus preceding 12 months

    −$19K

    3 active prime contractors · 4 awards

    View office comparison and evidence

    Reported obligations decreased 19.5% from $96K to $77K. The office’s share of positive obligations moved from 0.33% to 0.10%, a change of −0.2 percentage points.

    The latest period contains 6 actions across 4 awards. The preceding period contained 6 active prime contractors and 8 awards.

  6. Reported funding office

    AMC TRIPLER SHAFTER - MM

    #6Rank unchanged

    Latest 12 months

    $50K

    0.060% of positive obligations

    Versus preceding 12 months

    −$115K

    1 active prime contractor · 2 awards

    View office comparison and evidence

    Reported obligations decreased 69.8% from $165K to $50K. The office’s share of positive obligations moved from 0.57% to 0.060%, a change of −0.5 percentage points.

    The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 7 awards.

  7. Reported funding office

    633RD MDSS SGSL - MM

    #7New to the positive-obligation ranking

    Latest 12 months

    $41K

    0.050% of positive obligations

    Versus preceding 12 months

    +$41K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $41K. The office’s share of positive obligations moved from 0% to 0.050%, a change of +0.1 percentage points.

    The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 1 award.

  8. Reported funding office

    ACH WEED IRWIN - PA

    #8Up 9 from #17

    Latest 12 months

    $30K

    0.040% of positive obligations

    Versus preceding 12 months

    +$25K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations increased 512.2% from $5K to $30K. The office’s share of positive obligations moved from 0.020% to 0.040%, a change of 0.0 percentage points.

    The latest period contains 3 actions across 1 award. The preceding period contained 1 active prime contractor and 2 awards.

  9. Reported funding office

    NAV HSPTL SIGONELLA ITALY - MM

    #9New to the positive-obligation ranking

    Latest 12 months

    $29K

    0.040% of positive obligations

    Versus preceding 12 months

    +$29K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations rose from $0 to $29K. The office’s share of positive obligations moved from 0% to 0.040%, a change of 0.0 percentage points.

    The latest period contains 2 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.

  10. Reported funding office

    NAVAL MEDICAL RESEARCH CENTER

    #10Up 1 from #11

    Latest 12 months

    $15K

    0.020% of positive obligations

    Versus preceding 12 months

    −$32K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations decreased 67.2% from $47K to $15K. The office’s share of positive obligations moved from 0.16% to 0.020%, a change of −0.1 percentage points.

    The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 7 awards.

  11. Reported funding office

    DLA LAND AND MARITIME

    #11Down 4 from #7

    Latest 12 months

    $1

    0% of positive obligations

    Versus preceding 12 months

    −$109K

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations decreased 100.0% from $109K to $1. The office’s share of positive obligations moved from 0.38% to 0%, a change of −0.4 percentage points.

    The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 3 awards.

  12. Reported funding office

    DIRECTOR, WRNMMC

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$305K

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $305K to $0. The office’s share of positive obligations moved from 1.1% to 0%, a change of −1.1 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 4 active prime contractors and 5 awards.

  13. Reported funding office

    W6DZ CPE CBRND FT DETRICK

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$2.0M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $2.0M to $0. The office’s share of positive obligations moved from 6.9% to 0%, a change of −6.9 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.

    Leading award-level changes

Contract types, competition, and procurement methods

From Oct 24, 2025 through Oct 23, 2026, 31 awards had positive obligations totaling $79.4M. Only One Source was the leading reported procedure, accounting for 72.5% of positive obligations. Awards with a reported parent IDV accounted for 99.9%.

Leading award type
99.6%
Delivery Order
Leading reported procedure
72.5%
Only One Source
Reported parent IDV
99.9%
of positive obligations had a reported parent IDV
Median reported offers
1
11 of 31 awards reported offers

Buying method changes

Compared with Oct 24, 2024–Oct 23, 2025. Based on 31 current awards and 65 preceding awards with positive net obligations.

Reported full-and-open obligation share
27.1%
Down from 71.5% in the preceding period
Median positive award obligations
$49K
Up from $20K in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325414 peer median, parent-IDV obligation share is 11.6 percentage points higher, reported full-and-open obligation share is 42.5 percentage points lower, delivery-order obligation share is 11.3 percentage points higher, and median positive award obligations are 73.0% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share99.9%88.3%+11.6 pts
Reported full-and-open obligation share27.1%69.6%-42.5 pts
Delivery-order obligation share99.6%88.3%+11.3 pts
Median positive award obligations$49K$183K-73.0%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)20$79.1M99.6%
BPA Call(A)4$204K0.26%
Purchase Order(B)6$61K0.080%
Definitive Contract(D)1$49K0.060%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)20$79.1M99.6%
BPA(E)4$204K0.26%
Not reported7$110K0.14%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)24$79.3M99.9%
Not reported7$110K0.14%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Only One Source(SSS)8$57.6M72.5%
Negotiated Proposal/Quote(NP)11$21.5M27.1%
Simplified Acquisition(SP1)10$327K0.41%
Sp1(SIMPLIFIED ACQUISITION)2$7330%

Extent competed

Reported valueAwardsPositive obligationsShare
Not Available for Competition(B)4$56.6M71.3%
Full and Open Competition(A)11$21.5M27.1%
Not Competed(C)4$954K1.2%
Not Competed Under SAP(G)5$247K0.31%
Competed Under SAP(F)5$80K0.10%
G(NOT COMPETED UNDER SAP)1$4890%
Other reported values1$2440.0003%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Not reported31$79.4M100.0%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)8$57.6M72.5%
SAP Non-Competition (FAR 13)(SP2)6$248K0.31%
Not reported17$21.6M27.2%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)29$79.4M100.0%
J(FIRM FIXED PRICE)2$7330%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Drugs and Biologicals(6505)19$74.6M94.0%
Medical and Surgical Instruments, Equipment, and Supplies(6515)2$3.7M4.7%
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)5$941K1.2%
Laboratory Equipment and Supplies(6640)2$54K0.070%
Blood and Blood Products(6506)1$49K0.060%
Maint/Repair/Rebuild of Equipment- Instruments and Laboratory Equipment(J066)1$15K0.020%
Other reported values1$13K0.017%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Defense Logistics Agency(97AS)17$74.4M93.7%
Defense Health Agency(97DH)10$4.0M5.1%
Department of the Army(2100)3$955K1.2%
Department of the Navy(1700)1$15K0.020%

Awarding offices

Reported valueAwardsPositive obligationsShare
Dla Troop Support(SPE2DP)14$74.4M93.7%
Defense Health Agency(HT9427)2$3.7M4.7%
W40m Usa Hca(W81K04)2$926K1.2%
Defense Health Agency Hcd West(HT9410)1$113K0.14%
Defense Health Agency(HT9426)3$77K0.10%
Defense Health Agency(HT9406)2$70K0.090%
Other reported values7$96K0.12%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
SPE2DP26D0001(9700)2$52.9M66.6%
SPE2DP26D0006(9700)1$10.7M13.5%
SPE2DP26D0004(9700)4$8.7M11.0%
HT942525DE004(9700)2$3.7M4.7%
SPE2DP26D0005(9700)1$1.5M1.9%
W81K0425DA010(9700)2$926K1.2%
SPE2DP26D0003(9700)5$591K0.74%
HT941025A0002(9700)1$113K0.14%
Other reported values6$133K0.17%
Not reported7$110K0.14%

Offers, award size, and timing

Median reported offers
1 median
11 reported · 20 not reported
Positive award obligations
$49K median
$15K–$1.8M middle 50%
Reported performance period
175 days (~6 months) median
31 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
2 of 14prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
66.6%of positive obligations in the last 12 months
Leading four prime contractors
98.4%of positive obligations in the last 12 months
Leading eight prime contractors
99.9%of positive obligations in the last 12 months

Based on $79.4M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $52.9M

    66.6%

    Dollar movement

    +$52.9M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for MERIDIAN MEDICAL TECHNOLOGIES, LLC
    Obligations: prior → latest
    $0 → $52.9M
    Not comparable
    Share: prior → latest
    0% → 66.6%
    +66.6 percentage points
    All-period obligations
    $52.9M
    1.5% of all-period positive obligations · 5 awards
    Recorded activity
    Since Oct 21, 2021
    through Apr 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported20
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $12.2M

    15.4%

    Dollar movement

    +$7.6M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for SEQIRUS USA INC
    Obligations: prior → latest
    $4.6M → $12.2M
    +166.2%
    Share: prior → latest
    15.8% → 15.4%
    −0.4 percentage points
    All-period obligations
    $72.8M
    2.1% of all-period positive obligations · 18 awards
    Recorded activity
    Since Nov 24, 2021
    through Feb 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported21
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $9.3M

    11.7%

    Dollar movement

    −$6.9M

    vs. prior 12 months

    Last 12mo awards

    10 awards

    11 actions

    Historical and award details for SANOFI VACCINES US INC.
    Obligations: prior → latest
    $16.2M → $9.3M
    −42.4%
    Share: prior → latest
    55.8% → 11.7%
    −44.0 percentage points
    All-period obligations
    $35.2M
    1.0% of all-period positive obligations · 42 awards
    Recorded activity
    Since Nov 24, 2021
    through Apr 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported914
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $3.7M

    4.7%

    Dollar movement

    −$1.8M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for OCTAPHARMA USA INC
    Obligations: prior → latest
    $5.5M → $3.7M
    −32.4%
    Share: prior → latest
    18.9% → 4.7%
    −14.3 percentage points
    All-period obligations
    $9.2M
    0.26% of all-period positive obligations · 6 awards
    Recorded activity
    Since May 23, 2025
    through Mar 4, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported23
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $926K

    1.2%

    Dollar movement

    −$855K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for GREER LABORATORIES, INC.
    Obligations: prior → latest
    $1.8M → $926K
    −48.0%
    Share: prior → latest
    6.1% → 1.2%
    −5.0 percentage points
    All-period obligations
    $2.7M
    0.080% of all-period positive obligations · 5 awards
    Recorded activity
    Since Jun 6, 2025
    through Apr 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported23
    Reported small business23
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $163K

    0.21%

    Dollar movement

    −$18K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    3 actions

    Historical and award details for PROLACTA BIOSCIENCE, INC
    Obligations: prior → latest
    $181K → $163K
    −10.0%
    Share: prior → latest
    0.62% → 0.21%
    −0.4 percentage points
    All-period obligations
    $3.5M
    0.10% of all-period positive obligations · 39 awards
    Recorded activity
    Since Nov 9, 2021
    through Apr 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside39
    Not reported00
    Reported small business02
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $49K

    0.060%

    Dollar movement

    +$57K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for ZEN-BIO, INC.
    Obligations: prior → latest
    −$8K → $49K
    Not comparable
    Share: prior → latest
    0% → 0.060%
    +0.1 percentage points
    All-period obligations
    $145K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Jun 2, 2022
    through Mar 30, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business11
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $41K

    0.050%

    Dollar movement

    +$41K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for AMERICAN NATIONAL RED CROSS, THE
    Obligations: prior → latest
    $0 → $41K
    Not comparable
    Share: prior → latest
    0% → 0.050%
    +0.1 percentage points
    All-period obligations
    $2.0M
    0.060% of all-period positive obligations · 7 awards
    Recorded activity
    Since Nov 2, 2021
    through Feb 10, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $30K

    0.040%

    Dollar movement

    +$26K

    vs. prior 12 months

    Last 12mo awards

    1 award

    3 actions

    Historical and award details for LIFESTREAM BLOOD BANK
    Obligations: prior → latest
    $4K → $30K
    +653.6%
    Share: prior → latest
    0.010% → 0.040%
    0.0 percentage points
    All-period obligations
    $81K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Oct 26, 2021
    through Jan 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $29K

    0.040%

    Dollar movement

    +$29K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for INSTRUMENTATION LABORATORY S.P.A.
    Obligations: prior → latest
    $0 → $29K
    Not comparable
    Share: prior → latest
    0% → 0.040%
    0.0 percentage points
    All-period obligations
    $29K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Apr 9, 2026
    through Apr 16, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported10
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $15K

    0.020%

    Dollar movement

    −$40K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for LIFE TECHNOLOGIES CORPORATION
    Obligations: prior → latest
    $56K → $15K
    −72.3%
    Share: prior → latest
    0.19% → 0.020%
    −0.2 percentage points
    All-period obligations
    $249K
    0.010% of all-period positive obligations · 16 awards
    Recorded activity
    Since Oct 5, 2021
    through Dec 3, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside18
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $15K

    0.020%

    Dollar movement

    +$336

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for LAMPIRE BIOLOGICAL LABS INC
    Obligations: prior → latest
    $14K → $15K
    +2.3%
    Share: prior → latest
    0.050% → 0.020%
    0.0 percentage points
    All-period obligations
    $76K
    0% of all-period positive obligations · 2 awards
    Recorded activity
    Since Dec 2, 2021
    through Mar 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business11
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $13K

    0.020%

    Dollar movement

    −$2K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Obligations: prior → latest
    $15K → $13K
    −11.1%
    Share: prior → latest
    0.050% → 0.020%
    0.0 percentage points
    All-period obligations
    $51K
    0% of all-period positive obligations · 3 awards
    Recorded activity
    Since Feb 29, 2024
    through Apr 21, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported21
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $1

    0%

    Dollar movement

    −$145K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for BNB PLUS CORP.
    Obligations: prior → latest
    $145K → $1
    −100.0%
    Share: prior → latest
    0.50% → 0%
    −0.5 percentage points
    All-period obligations
    $614K
    0.020% of all-period positive obligations · 18 awards
    Recorded activity
    Since Dec 7, 2021
    through Dec 15, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported14
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    −$3K

    0%

    Dollar movement

    −$4K

    vs. prior 12 months

    Last 12mo awards

    6 awards

    6 actions

    Historical and award details for BIOMERIEUX INC
    Obligations: prior → latest
    $914 → −$3K
    Not comparable
    Share: prior → latest
    0% → 0%
    0.0 percentage points
    All-period obligations
    $14K
    0% of all-period positive obligations · 50 awards
    Recorded activity
    Since Nov 10, 2021
    through Mar 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside615
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

MERIDIAN MEDICAL TECHNOLOGIES, LLC

8512025830!ANTIDOTE TREATMENT

The reported potential end date is Jan 7, 2027. Current award value is 100.0% of reported potential value ($36.5M of $36.5M).

Performance period

72.4%

As of Oct 23, 2026Potential end Jan 7, 2027

Current award value as a share of potential value

100.0%

$36.5M current$36.5M potential
Supporting data

Reported performance starts Apr 7, 2026.

No later potential end date is reported; current and potential end dates are both Jan 7, 2027.

$36.5M is obligated against $36.5M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID SPE2DP26F4183

These are research leads, not confirmed recompetes. USAspending records through Oct 23, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Base award

This action

+$36.5M

MERIDIAN MEDICAL TECHNOLOGIES, LLC

DLA TROOP SUPPORT

8512025830!ANTIDOTE TREATMENT

Why it stands out

One action equaled more than a third of the market’s latest 12-month positive obligations.

The $36.5M action represented 45.9% of the market’s positive obligations over the latest 12 months.

Award net obligations
$36.5M
Share of 12-month positive obligations
45.9%
Supporting data
Prime contractor
#1 · 66.6% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#1 · 93.7% attributed share
+22.1 percentage points · $53.6M net increase; action accounted for 68.0%
Related:Funding office gainUnusually large action
PIID SPE2DP26F4183
Base award

This action

+$10.7M

SEQIRUS USA INC

DLA TROOP SUPPORT

8511922204!INFLUENZA VIRUS VAC

Why it stands out

One action represented 13.5% of the market’s latest 12-month positive obligations.

At $10.7M, the action was large enough to materially affect the latest 12-month market picture.

Award net obligations
$10.7M
Share of 12-month positive obligations
13.5%
Supporting data
Prime contractor
#2 · 15.4% share
up 1 rank · −0.4 percentage points · $7.6M net increase; action exceeded it by $3.1M
Related:Largest contractor gain
PIID SPE2DP26F2834
Base award

This action

+$16.4M

MERIDIAN MEDICAL TECHNOLOGIES, LLC

DLA TROOP SUPPORT

8511797933!ANTIDOTE TREATMENT

Why it stands out

One action equaled about a fifth of the market’s latest 12-month positive obligations.

The $16.4M action represented 20.7% of the market’s positive obligations over the latest 12 months.

Award net obligations
$16.4M
Share of 12-month positive obligations
20.7%
PIID SPE2DP26F1088
Base award

This action

+$1.9M

OCTAPHARMA USA INC

ARMY MMDA - MM

1,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 2.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1.8M overall.

Award net obligations
$1.9M
Share of 12-month positive obligations
2.4%
Supporting data
Prime contractor
#4 · 4.7% share
$1.8M net decline despite this positive action
Funding office
#2 · 4.7% attributed share
−7.4 percentage points · $220K net increase; action exceeded it by $1.7M
PIID HT942726FE009
Base award

This action

+$3.0M

SANOFI VACCINES US INC.

DLA TROOP SUPPORT

8511928943!INFLUENZA VIRUS VAC

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 3.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $6.9M overall.

Award net obligations
$3.0M
Share of 12-month positive obligations
3.8%
Supporting data
Prime contractor
#3 · 11.7% share
$6.9M net decline despite this positive action
PIID SPE2DP26F2910
Base award

This action

+$470K

GREER LABORATORIES, INC.

KIMBROUGH AMB CC MEADE - MM

ALLERGEN EXTRACT SUPPLIES

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 0.59% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $855K overall.

Award net obligations
$470K
Share of 12-month positive obligations
0.59%
Supporting data
Prime contractor
#5 · 1.2% share
$855K net decline despite this positive action
Funding office
#3 · 1.2% attributed share
$855K net decline despite this positive action
PIID W81K0426FA037
View recent award activity by date (10)
  1. UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.Base award · PIID HT942626FE037
    Action+$13K
    Award net obligations$13K
  2. PROLACTA BIOSCIENCE, INCBase award · PIID HT941026FE035
    Action+$113K
    Award net obligations$113K
  3. INSTRUMENTATION LABORATORY S.P.A.Base award · PIID HT940626FE042
    Action+$29K
    Award net obligations$29K
  4. GREER LABORATORIES, INC.Base award · PIID W81K0426FA193
    Action+$455K
    Award net obligations$455K
  5. MERIDIAN MEDICAL TECHNOLOGIES, LLCBase award · PIID SPE2DP26F4183
    Action+$36.5M
    Award net obligations$36.5M
  6. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F4178
    Action+$3K
    Award net obligations$3K
  7. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F4066
    Action+$2K
    Award net obligations$2K
  8. SANOFI VACCINES US INC.Base award · PIID SPE2DP26F3981
    Action+$87K
    Award net obligations$87K
  9. BIOMERIEUX INCBase award · PIID SPE2DS26P1391
    Action+$489
    Award net obligations$489
  10. ZEN-BIO, INC.Modification · PIID HT942626CE004
    Action+$6K
    Award net obligations$49K

DoD biological product (except diagnostic) manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top DoD biological product (except diagnostic) manufacturing contractors?

In the 12 months through October 23, 2026, MERIDIAN MEDICAL TECHNOLOGIES, LLC, SEQIRUS USA INC, and SANOFI VACCINES US INC. were the leading DoD biological product (except diagnostic) manufacturing prime contractors by positive obligations.

  1. #1

    MERIDIAN MEDICAL TECHNOLOGIES, LLC

    $52,881,500 in positive obligations

  2. #2

    SEQIRUS USA INC

    $12,212,593 in positive obligations

  3. #3

    SANOFI VACCINES US INC.

    $9,326,440 in positive obligations

Rankings use reported USAspending award data.

Did DoD contract obligations increase in the biological product (except diagnostic) manufacturing market?

Yes. Measured by net prime contract obligations, reported DoD activity in the biological product (except diagnostic) manufacturing market increased 173.6% from $29,026,006 in the preceding 12 months to $79,417,480 in the 12 months through October 23, 2026.

Latest 12 months
$79,417,480
Net prime contract obligations
Preceding 12 months
$29,026,006
Net prime contract obligations
Change
+173.6%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent DoD contract award activity was reported in the biological product (except diagnostic) manufacturing market?

Recent DoD contract award activity reported in the biological product (except diagnostic) manufacturing market included actions for MERIDIAN MEDICAL TECHNOLOGIES, LLC, SEQIRUS USA INC, and OCTAPHARMA USA INC during the 12 months through October 23, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for DoD contracts under NAICS 325414?

From October 24, 2025 through October 23, 2026, DoD reported 31 positive-obligation awards for biological product (except diagnostic) manufacturing under NAICS 325414. The leading award type was delivery order. The leading reported procedure was only one source.

Positive-obligation awards
31
Leading reported procedure
Only One Source
72.5% of positive obligations
Leading award type
Delivery Order
99.6% of positive obligations
Full and open
27.1%
of positive obligations
Reported parent IDV
99.9%
of positive obligations

Percentages use positive obligations as the denominator.

Which DoD biological product (except diagnostic) manufacturing awards may warrant recompete research?

Based on its reported potential-end date, the DoD biological product (except diagnostic) manufacturing award held by MERIDIAN MEDICAL TECHNOLOGIES, LLC may warrant recompete research.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.

Review data methodology